Tourmaline Bio Inc. • TRML

Capital at risk.

About Tourmaline Bio Inc.
Ticker
info
TRML
Trading on
info
NASDAQ
ISIN
info
US89157D1054
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Sandeep C. Kulkarni M.D.
Headquarters
info
27 West 24th Street, New York, NY, United States, 10010
Employees
info
76
Website
info
tourmalinebio.com
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases. It develops TOUR006, a human anti-IL-6 monoclonal antibody that selectively binds to interleukin-6, a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The company's development pipeline comprises medicines and therapies for the atherosclerotic cardiovascular disease (ASCVD) and thyroid eye disease (TED). The company was formerly known as Tourmaline Bio, LLC and changed its name to Tourmaline Bio, Inc. in September 2022. Tourmaline Bio, Inc. was founded in 2021 and is headquartered in New York, New York. Tourmaline Bio, Inc. operates as a subsidiary of Novartis AG.
Metrics
BasicAdvanced
Market cap
info
$1.23B
P/E ratio
info
-
EPS
info
-$3.44
Dividend Yield
info
0.00%
Beta
info
1.58
Forward P/E ratio
info
0
EBIDTA
info
$-102M
Ex dividend date
info
-
Price & volume
Market cap
info
$1.23B
Average daily volume
info
0.7M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
4.75
Earnings
EPS
info
-$3.44
EPS estimate (current quarter)
info
-$0.93
EPS estimate (next quarter)
info
-$0.98
EBITDA
info
$-102M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
1.58
52-week High
info
$48.27
52-week Low
info
$11.56
50-day moving average
info
$42.23
200-day moving average
info
$23.14
Short ratio
info
1.12
Short %
info
3.52%
Management effectiveness
ROE (TTM)
info
-29.62%
ROA (TTM)
info
-20.85%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
25.7M
Float
info
13.1M
Insiders %
info
14.62%
Institutions %
info
89.13%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 11 analysts.

Average price target

info
$48.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.78
-$0.82
4.88%
Q3 • 24Beat
-$0.86
-$0.87
1.15%
Q4 • 24Beat
-$0.89
-$0.94
4.95%
Q1 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-23M
-∞%
Q1 • 25
$0M
$-23.1M
-∞%
Q2 • 25
NaN%
0.53%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$287M
$7.6M
2.66%
Q1 • 25
$269M
$10.1M
3.75%
Q2 • 25
-6.33%
32.32%
41.27%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-21.7M
$25.9M
$0.6M
$-21.7M
Q1 • 25
$-20.3M
$16.3M
$0.1M
$-20.3M
Q2 • 25
-6.53%
-37.15%
-90.39%
-6.53%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Tourmaline Bio Inc. share?
Collapse

Tourmaline Bio Inc. shares are currently traded for undefined per share.

How many shares does Tourmaline Bio Inc. have?
Collapse

Tourmaline Bio Inc. currently has 25.7M shares.

Does Tourmaline Bio Inc. pay dividends?
Collapse

No, Tourmaline Bio Inc. doesn't pay dividends.

What is Tourmaline Bio Inc. 52 week high?
Collapse

Tourmaline Bio Inc. 52 week high is $48.27.

What is Tourmaline Bio Inc. 52 week low?
Collapse

Tourmaline Bio Inc. 52 week low is $11.56.

What is the 200-day moving average of Tourmaline Bio Inc.?
Collapse

Tourmaline Bio Inc. 200-day moving average is $23.14.

Who is Tourmaline Bio Inc. CEO?
Collapse

The CEO of Tourmaline Bio Inc. is Dr. Sandeep C. Kulkarni M.D..

How many employees Tourmaline Bio Inc. has?
Collapse

Tourmaline Bio Inc. has 76 employees.

What is the market cap of Tourmaline Bio Inc.?
Collapse

The market cap of Tourmaline Bio Inc. is $1.23B.

What is the P/E of Tourmaline Bio Inc.?
Collapse

The current P/E of Tourmaline Bio Inc. is null.

What is the EPS of Tourmaline Bio Inc.?
Collapse

The EPS of Tourmaline Bio Inc. is -$3.44.

What is the PEG Ratio of Tourmaline Bio Inc.?
Collapse

The PEG Ratio of Tourmaline Bio Inc. is null.

What do analysts say about Tourmaline Bio Inc.?
Collapse

According to the analysts Tourmaline Bio Inc. is considered a buy.